MicroRNAs (miRNAs) play a critical regulatory role in the mammalian immune system, influencing immune development, function, and responses. Genetic ablation of miRNA machinery or loss of specific miRNAs leads to immune disorders such as autoimmunity and cancer. miRNAs regulate protein output by modulating the concentrations of key cellular proteins involved in essential pathways. They are encoded in the genome and processed through a series of enzymatic steps to produce mature miRNAs that guide the RNA-induced silencing complex (RISC) to target mRNAs, leading to translational repression, mRNA cleavage, or decay. miRNAs can also upregulate translation or interfere with gene transcription under certain conditions. Studies show that miRNAs are essential for lymphocyte development and differentiation. For example, Dicer deficiency in T or B cells leads to severe defects in thymocyte development and T regulatory cell function. miR-155 and miR-17~92 clusters are involved in various immune processes, including B cell development, T cell signaling, and immune responses. miR-155 regulates class-switched B cells and c-myc-IgH translocations, while miR-17~92 controls multiple pathways, including the PI3K pathway and cell cycle regulation. miRNAs also play a role in host-virus interactions, helping viruses evade immune responses by regulating gene expression. Some viruses encode miRNAs that target host or viral mRNAs, while cellular miRNAs can contribute to antiviral defense. miRNAs are involved in hematopoietic malignancies, with deregulated miRNA expression contributing to cancer progression and tumor metastasis. Overall, miRNAs regulate immune development and function through complex, dose-dependent mechanisms, targeting multiple components of regulatory networks. Their ability to rapidly evolve and adapt makes them important in immune responses to pathogens. Understanding miRNA control in the immune system has significant implications for both basic research and the development of therapeutic strategies for immune-related diseases.MicroRNAs (miRNAs) play a critical regulatory role in the mammalian immune system, influencing immune development, function, and responses. Genetic ablation of miRNA machinery or loss of specific miRNAs leads to immune disorders such as autoimmunity and cancer. miRNAs regulate protein output by modulating the concentrations of key cellular proteins involved in essential pathways. They are encoded in the genome and processed through a series of enzymatic steps to produce mature miRNAs that guide the RNA-induced silencing complex (RISC) to target mRNAs, leading to translational repression, mRNA cleavage, or decay. miRNAs can also upregulate translation or interfere with gene transcription under certain conditions. Studies show that miRNAs are essential for lymphocyte development and differentiation. For example, Dicer deficiency in T or B cells leads to severe defects in thymocyte development and T regulatory cell function. miR-155 and miR-17~92 clusters are involved in various immune processes, including B cell development, T cell signaling, and immune responses. miR-155 regulates class-switched B cells and c-myc-IgH translocations, while miR-17~92 controls multiple pathways, including the PI3K pathway and cell cycle regulation. miRNAs also play a role in host-virus interactions, helping viruses evade immune responses by regulating gene expression. Some viruses encode miRNAs that target host or viral mRNAs, while cellular miRNAs can contribute to antiviral defense. miRNAs are involved in hematopoietic malignancies, with deregulated miRNA expression contributing to cancer progression and tumor metastasis. Overall, miRNAs regulate immune development and function through complex, dose-dependent mechanisms, targeting multiple components of regulatory networks. Their ability to rapidly evolve and adapt makes them important in immune responses to pathogens. Understanding miRNA control in the immune system has significant implications for both basic research and the development of therapeutic strategies for immune-related diseases.